<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.4.0 for Hugo" />
  

  
  









  




  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
  

  

  
  
  
    
  
  <meta name="description" content="PURPOSE: To survey the clinical responses to treatment of chronic postoperative and uveitic cystoid macular edema (CME) with a dexamethasone-based intravitreal implant (Ozurdex(®)). METHODS: This retrospective, interventional case series reports on patients with chronic CME after uncomplicated vitrectomy for epiretinal gliosis or phacoemulsification (group 1: 12 eyes) or secondary to noninfectious endogenous uveitis (group 2: 36 eyes). Central retinal thickness (CRT), best-corrected visual acuity (BCVA, logMAR), and intraocular pressure (IOP) throughout follow-up were gleaned from the medical records. RESULTS: In group 1, CRT decreased, compared with baseline, from 519 $±$ 43 to 297 $±$ 23 and 356 $±$ 49 $μ$m by the 1- and 3-month visit (P = 0.02) and to 429 $±$ 57 $μ$m before reimplantation. In group 2, CRT decreased from 460 $±$ 31 to 300 $±$ 21 and 312 $±$ 26 $μ$m by the 1- and 3-month follow-up, respectively (P = 0.001), and to 373 $±$ 32 $μ$m before reimplantation. Complete resolution of CME was achieved in 67% and 94% (groups 1 and 2, respectively) by 1 month and in 42% and 80% by 3 months after injection. In group 1, BCVA improved from 0.46 $±$ 0.08 to 0.27 $±$ 0.09 and 0.20 $±$ 0.06 (P = 0.01) by the 1- and 3-month follow-up, respectively, and to 0.32 $±$ 0.08 before reimplantation. In group 2, BCVA improved from 0.47 $±$ 0.06 to 0.34 $±$ 0.09, 0.26 $±$ 0.07, and 0.29 $±$ 0.08 (P &lt; 0.05) at 1 and 3 months of follow-up and before reimplantation, respectively. A significant IOP increase was not observed in either group. Mean time to reimplantation of Ozurdex was 6.4 $±$ 5.7 and 6.6 $±$ 3.4 months for postoperative and uveitic CME, respectively. CONCLUSION: Ozurdex seems to achieve a sustained effect over up to 6 months in postsurgical and uveitic CME." />

  
  <link rel="alternate" hreflang="en-us" href="https://pfaulab.com/publication/garweg-2016-rt/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.f1ecf783c14edc00c9320c205831ad8e.css" media="print" onload="this.media='all'">

  
  
  
    
    

    
    
    
    
      
      
    
    
    

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/github.min.css" crossorigin="anonymous" title="hl-light" media="print" onload="this.media='all'">
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" media="print" onload="this.media='all'" disabled>
        
      
    

    
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.css" integrity="" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.512574799414e7d36471486881070b0f.css" />

  




<script async src="https://www.googletagmanager.com/gtag/js?id=G-MJX7QL4CZN"></script>
<script>
  window.dataLayer = window.dataLayer || [];

  function gtag() {
      dataLayer.push(arguments);
  }

  function trackOutboundLink(url, target) {
    gtag('event', 'click', {
         'event_category': 'outbound',
         'event_label': url,
         'transport_type': 'beacon',
         'event_callback': function () {
           if (target !== '_blank') {
             document.location = url;
           }
         }
    });
    console.debug("Outbound link clicked: " + url);
  }

  function onClickCallback(event) {
    if ((event.target.tagName !== 'A') || (event.target.host === window.location.host)) {
      return;
    }
    trackOutboundLink(event.target, event.target.getAttribute('target'));  
  }

  gtag('js', new Date());
  gtag('config', 'G-MJX7QL4CZN', {});
  gtag('set', {'cookie_flags': 'SameSite=None;Secure'});

  
  document.addEventListener('click', onClickCallback, false);
</script>


  

  

  




  
  
  

  

  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://pfaulab.com/publication/garweg-2016-rt/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@https://twitter.com/maximilianpfau3" />
    <meta property="twitter:creator" content="@https://twitter.com/maximilianpfau3" />
  
  <meta property="og:site_name" content="Pfau Lab" />
  <meta property="og:url" content="https://pfaulab.com/publication/garweg-2016-rt/" />
  <meta property="og:title" content="Response of postoperative and chronic uveitic cystoid macular edema to a dexamethasone-based intravitreal implant (Ozurdex) | Pfau Lab" />
  <meta property="og:description" content="PURPOSE: To survey the clinical responses to treatment of chronic postoperative and uveitic cystoid macular edema (CME) with a dexamethasone-based intravitreal implant (Ozurdex(®)). METHODS: This retrospective, interventional case series reports on patients with chronic CME after uncomplicated vitrectomy for epiretinal gliosis or phacoemulsification (group 1: 12 eyes) or secondary to noninfectious endogenous uveitis (group 2: 36 eyes). Central retinal thickness (CRT), best-corrected visual acuity (BCVA, logMAR), and intraocular pressure (IOP) throughout follow-up were gleaned from the medical records. RESULTS: In group 1, CRT decreased, compared with baseline, from 519 $±$ 43 to 297 $±$ 23 and 356 $±$ 49 $μ$m by the 1- and 3-month visit (P = 0.02) and to 429 $±$ 57 $μ$m before reimplantation. In group 2, CRT decreased from 460 $±$ 31 to 300 $±$ 21 and 312 $±$ 26 $μ$m by the 1- and 3-month follow-up, respectively (P = 0.001), and to 373 $±$ 32 $μ$m before reimplantation. Complete resolution of CME was achieved in 67% and 94% (groups 1 and 2, respectively) by 1 month and in 42% and 80% by 3 months after injection. In group 1, BCVA improved from 0.46 $±$ 0.08 to 0.27 $±$ 0.09 and 0.20 $±$ 0.06 (P = 0.01) by the 1- and 3-month follow-up, respectively, and to 0.32 $±$ 0.08 before reimplantation. In group 2, BCVA improved from 0.47 $±$ 0.06 to 0.34 $±$ 0.09, 0.26 $±$ 0.07, and 0.29 $±$ 0.08 (P &lt; 0.05) at 1 and 3 months of follow-up and before reimplantation, respectively. A significant IOP increase was not observed in either group. Mean time to reimplantation of Ozurdex was 6.4 $±$ 5.7 and 6.6 $±$ 3.4 months for postoperative and uveitic CME, respectively. CONCLUSION: Ozurdex seems to achieve a sustained effect over up to 6 months in postsurgical and uveitic CME." /><meta property="og:image" content="https://pfaulab.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://pfaulab.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2024-07-19T21:40:31&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2024-07-19T23:40:32&#43;02:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://pfaulab.com/publication/garweg-2016-rt/"
  },
  "headline": "Response of postoperative and chronic uveitic cystoid macular edema to a dexamethasone-based intravitreal implant (Ozurdex)",
  
  "datePublished": "2024-07-19T21:40:31Z",
  "dateModified": "2024-07-19T23:40:32+02:00",
  
  "author": {
    "@type": "Person",
    "name": "Justus G Garweg"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Pfau Lab",
    "logo": {
      "@type": "ImageObject",
      "url": "https://pfaulab.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "PURPOSE: To survey the clinical responses to treatment of chronic postoperative and uveitic cystoid macular edema (CME) with a dexamethasone-based intravitreal implant (Ozurdex(®)). METHODS: This retrospective, interventional case series reports on patients with chronic CME after uncomplicated vitrectomy for epiretinal gliosis or phacoemulsification (group 1: 12 eyes) or secondary to noninfectious endogenous uveitis (group 2: 36 eyes). Central retinal thickness (CRT), best-corrected visual acuity (BCVA, logMAR), and intraocular pressure (IOP) throughout follow-up were gleaned from the medical records. RESULTS: In group 1, CRT decreased, compared with baseline, from 519 $±$ 43 to 297 $±$ 23 and 356 $±$ 49 $μ$m by the 1- and 3-month visit (P = 0.02) and to 429 $±$ 57 $μ$m before reimplantation. In group 2, CRT decreased from 460 $±$ 31 to 300 $±$ 21 and 312 $±$ 26 $μ$m by the 1- and 3-month follow-up, respectively (P = 0.001), and to 373 $±$ 32 $μ$m before reimplantation. Complete resolution of CME was achieved in 67% and 94% (groups 1 and 2, respectively) by 1 month and in 42% and 80% by 3 months after injection. In group 1, BCVA improved from 0.46 $±$ 0.08 to 0.27 $±$ 0.09 and 0.20 $±$ 0.06 (P = 0.01) by the 1- and 3-month follow-up, respectively, and to 0.32 $±$ 0.08 before reimplantation. In group 2, BCVA improved from 0.47 $±$ 0.06 to 0.34 $±$ 0.09, 0.26 $±$ 0.07, and 0.29 $±$ 0.08 (P \u003c 0.05) at 1 and 3 months of follow-up and before reimplantation, respectively. A significant IOP increase was not observed in either group. Mean time to reimplantation of Ozurdex was 6.4 $±$ 5.7 and 6.6 $±$ 3.4 months for postoperative and uveitic CME, respectively. CONCLUSION: Ozurdex seems to achieve a sustained effect over up to 6 months in postsurgical and uveitic CME."
}
</script>

  

  

  

  





  <title>Response of postoperative and chronic uveitic cystoid macular edema to a dexamethasone-based intravitreal implant (Ozurdex) | Pfau Lab</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="0ca23e6161b4b950a22284573a433717" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.8f76bdc9e086322ed5147724ebba3d06.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">Pfau Lab</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">Pfau Lab</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-end" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#posts"><span>News</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#publications"><span>Publications</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#people"><span>Team</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#contact"><span>Contact</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        

        
        

        
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Response of postoperative and chronic uveitic cystoid macular edema to a dexamethasone-based intravitreal implant (Ozurdex)</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      <a href="/author/justus-g-garweg/">Justus G Garweg</a></span>, <span >
      <a href="/author/edoardo-baglivo/">Edoardo Baglivo</a></span>, <span >
      <a href="/author/florentina-j-freiberg/">Florentina J Freiberg</a></span>, <span >
      <a href="/author/maximilian-pfau/">Maximilian Pfau</a></span>, <span >
      <a href="/author/isabel-b-pfister/">Isabel B Pfister</a></span>, <span >
      <a href="/author/stephan-michels/">Stephan Michels</a></span>, <span >
      <a href="/author/souska-zandi/">Souska Zandi</a></span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    September 2016
  </span>
  

  

  

  
  
  
  
  
  

  
  

</div>

    




<div class="btn-links mb-3">
  
  








  





<a href="#" class="btn btn-outline-primary btn-page-header js-cite-modal"
        data-filename="/publication/garweg-2016-rt/cite.bib">
  Cite
</a>















</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">PURPOSE: To survey the clinical responses to treatment of chronic postoperative and uveitic cystoid macular edema (CME) with a dexamethasone-based intravitreal implant (Ozurdex(®)). METHODS: This retrospective, interventional case series reports on patients with chronic CME after uncomplicated vitrectomy for epiretinal gliosis or phacoemulsification (group 1: 12 eyes) or secondary to noninfectious endogenous uveitis (group 2: 36 eyes). Central retinal thickness (CRT), best-corrected visual acuity (BCVA, logMAR), and intraocular pressure (IOP) throughout follow-up were gleaned from the medical records. RESULTS: In group 1, CRT decreased, compared with baseline, from 519 $±$ 43 to 297 $±$ 23 and 356 $±$ 49 $μ$m by the 1- and 3-month visit (P = 0.02) and to 429 $±$ 57 $μ$m before reimplantation. In group 2, CRT decreased from 460 $±$ 31 to 300 $±$ 21 and 312 $±$ 26 $μ$m by the 1- and 3-month follow-up, respectively (P = 0.001), and to 373 $±$ 32 $μ$m before reimplantation. Complete resolution of CME was achieved in 67% and 94% (groups 1 and 2, respectively) by 1 month and in 42% and 80% by 3 months after injection. In group 1, BCVA improved from 0.46 $±$ 0.08 to 0.27 $±$ 0.09 and 0.20 $±$ 0.06 (P = 0.01) by the 1- and 3-month follow-up, respectively, and to 0.32 $±$ 0.08 before reimplantation. In group 2, BCVA improved from 0.47 $±$ 0.06 to 0.34 $±$ 0.09, 0.26 $±$ 0.07, and 0.29 $±$ 0.08 (P &lt; 0.05) at 1 and 3 months of follow-up and before reimplantation, respectively. A significant IOP increase was not observed in either group. Mean time to reimplantation of Ozurdex was 6.4 $±$ 5.7 and 6.6 $±$ 3.4 months for postoperative and uveitic CME, respectively. CONCLUSION: Ozurdex seems to achieve a sustained effect over up to 6 months in postsurgical and uveitic CME.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>J. Ocul. Pharmacol. Ther.</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    


















  
  
    




  
    




  
    




  
    




  
    




  
    




  
    




  














  
  





  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  



  

  

  
  <p class="powered-by">
    © {2022} Maximilian Pfau
  </p>
  

  
  






  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      

    
    <script src="/js/vendor-bundle.min.b73dfaac3b6499dc997741748a7c3fe2.js"></script>

    
    
    
      
      
        <script src="https://cdn.jsdelivr.net/gh/desandro/imagesloaded@v4.1.4/imagesloaded.pkgd.min.js" integrity="sha512-S5PZ9GxJZO16tT9r3WJp/Safn31eu8uWrzglMahDT4dsmgqWonRY9grk3j+3tfuPr9WJNsfooOR7Gi7HL5W2jw==" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/gh/metafizzy/isotope@v3.0.6/dist/isotope.pkgd.min.js" integrity="sha512-Zq2BOxyhvnRFXu0+WE6ojpZLOU2jdnqbrM1hmVdGzyeCa1DgM3X5Q4A/Is9xA1IkbUeDd7755dNNI/PzSf2Pew==" crossorigin="anonymous"></script>
      

      
      

      

      
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/highlight.min.js" integrity="sha512-Ypjm0o7jOxAd4hpdoppSEN0TQOC19UtPAqD+4s5AlXmUvbmmS/YMxYqAqarQYyxTnB6/rqip9qcxlNB/3U9Wdg==" crossorigin="anonymous"></script>
        
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/r.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/python.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/latex.min.js" crossorigin="anonymous"></script>
        
      

    

    
    
    
      <script src="https://cdn.jsdelivr.net/npm/leaflet@1.7.1/dist/leaflet.min.js" integrity="" crossorigin="anonymous"></script>
    

    
    

    
    
    
      
      <script id="search-hit-fuse-template" type="text/x-template">
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script>
      
        <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
      
    

    
    

    
    
    
    

    
    
      
      
      
      
      
      
      
    

    

    
    
    
    <script id="page-data" type="application/json">{"use_headroom":true}</script>

    
    
      <script src="/js/wowchemy-headroom.1cb9e2fc8399acee94eab837265b73bf.js" type="module"></script>
    
    
    
    
    
    
    
      
      
    
    
    <script src="/en/js/wowchemy.min.247fd8f54253895301106e3006f53f38.js"></script>

    
  <script async defer src="https://buttons.github.io/buttons.js"></script>




</body>
</html>
